XFLT Board escalates proxy fight, warning that a vote against the King Street sub-adviser will leave the fund in limbo
XFLT sits 17% above its 52-week low of $14.925.
Summary
On July 16, 2026, XFLT's Board published new letters and a presentation that escalate the proxy fight by highlighting Octagon's alleged seven CLO defaults in 2026 and warning that a 'no' vote will not bring Octagon back but will leave the Fund without a sub-adviser.
Key Events · Corporate Governance and Compliance · XFLT
-
Board Publishes New Proxy Materials
On July 16, 2026, XFLT's Board released two new shareholder letters and a comprehensive presentation urging shareholders to vote FOR the King Street sub-advisory agreement at the July 30 special meeting.
-
New Allegations Against Octagon
The Board claims Octagon's CLO portfolio suffered seven defaults in 2026 that wiped out entire classes of investors, a new specific allegation not made in prior filings.
-
Warning on Consequences of 'No' Vote
A vote against the proposal will not reinstate Octagon, the Board warns, but will instead force the Fund into a prolonged limbo while the Board restarts the search for a qualified sub-adviser.
-
Proxy Contest Intensifies Ahead of July 30 Meeting
This filing is the latest in a series of back-and-forth proxy materials between the Board and Octagon, with the special meeting scheduled for July 30, 2026.
Analysis · XFLT · Unknown
The Board's latest proxy materials sharpen its attack on terminated sub-adviser Octagon, alleging for the first time that Octagon's CLO portfolio suffered seven defaults in 2026 that wiped out entire investor classes. It also warns that a vote against the King Street sub-advisory agreement will not reinstate Octagon but will instead force a prolonged search for another sub-adviser, leaving the Fund in limbo. These new, material arguments aim to sway shareholders ahead of the July 30 special meeting, intensifying an already contentious proxy contest.
At the time of this filing, XFLT was trading at $17.42 on NYSE in the Unknown sector, with a market capitalization of approximately $264.7M. The 52-week trading range was $14.93 to $28.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.